Efficacy and Safety of Postbiotic Contained Inactivated Lactobacillus reuteri ( Limosilactobacillus reuteri ) DSM 17648 as Adjuvant Therapy in the Eradication of Helicobacter pylori in Adults With Functional Dyspepsia: A Randomized Double-Blind Placebo-Controlled Trial.
Vladimir IvashkinIgor MaevElena PoluektovaAlexander SinitsaElena AvaluevaMarina MnatsakanyanVladimir SimanenkovJulia KarpeevaDaria KopylovaIrina KuprinaYury KucheryavyyTatiana LapinaOlga SolovyevaMalle SoomNatalia CheremushkinaEvgeniya MaevskayaRoman V MaslennikovPublished in: Clinical and translational gastroenterology (2024)
The postbiotic containing inactivated L. reuteri DSM 17648 significantly improves the effectiveness of H. pylori eradication therapy in FD and decreases overall number of digestive adverse effects of this therapy.